SCHEMBL10074852

SCHEMBL10074852

COc1ccc(C2CC(c3ccc(Br)cc3)=NN2C(=O)CCC(=O)O)cc1OC

nearest known ligand 0.84

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.68
KDM4E B2RXH2 2/20 0.64
ALDH1A1 P00352 2/20 0.64
MAOB P27338 2/20 0.62
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.57
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
MAOA P21397 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
RNF114 Q9Y508 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314287 0.92 KDM4E (0.74) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL31574569 0.90 POLB (0.68) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL14444134 0.89 POLB (0.67) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL22420541 0.85 KDM4E (0.66) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL22420546 0.85 MAOB (0.72) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL3311061 0.85 KDM4E (0.70) POLBKDM4EALDH1A1KMT2AL3MBTL1
SCHEMBL3319335 0.85 KDM4E (0.70) POLBKDM4EALDH1A1KMT2AMEN1
SCHEMBL10050566 0.85 EGFR (0.64) KMT2AMEN1L3MBTL1RNF114
SCHEMBL3313199 0.85 KDM4E (0.75) POLBKDM4EALDH1A1MAOBKMT2A
SCHEMBL3318074 0.84 KDM4E (0.69) POLBKDM4EALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150010493-A1 SMALL MOLECULE INHIBITORS OF RNA SILENCING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-01-08 US disclosed
US-20120077804-A1 Small Molecule Inhibitors of RNA Silencing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-03-29 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
WO-2009018084-A1 SMALL MOLECULE INHIBITORS OF RNA SILENCING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 POLB 3681/4885KDM4E 2546/4885ALDH1A1 1386/4885
US-20120077804-A1 Small Molecule Inhibitors of RNA Silencing AGO2, EMG1, ZFR POLB 1860/4885KDM4E 618/4885ALDH1A1 4420/4885
US-20150010493-A1 SMALL MOLECULE INHIBITORS OF RNA SILENCING AGO2, EMG1, ZFR POLB 1860/4885KDM4E 618/4885ALDH1A1 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.